Talking Stocks 2.0

[vipereaper30]

Originally Posted by 7sins

That is directionally BULLISH with massive call buying and a very low put/call ratio, a positive sign to form for a reversal.

That article should have been titled "Due to TRF Investment Club, Sabre call volume above normal and directionally bullish"

:strong:

[logo]

Originally Posted by 7sins

Where are you allocating on this? Adding to the warrants or underlying stock, SP which seems like a deal at $9.80? Trouble deciding between the two.



HAHA tell her to support the cause, I bought some cologne last week


Some good news for us on SABR after a challenging day with delta fears rising.

That is directionally BULLISH with massive call buying and a very low put/call ratio, a positive sign to form for a reversal. The april 22 $10c took a beating today, starting adding there as it is these downward drafts where you can really make money. SABR is now NEGATIVE YTD, truly believe this is oversold given the rebound we are seeing in travel.

Also began starter position in TBT jan 2023 $18C and will add if rates keep moving down, can't see rates staying sub 1.30%. Looking at June 2022 TBT chain as well, those are priced well with a decent runway. As always, just my .02 and some moves I am making, not financial advice by any means.

If you don't subscribe to TheFly (stupid name) News, I would highly highly encourage you to. Great way to get updates along the day for opportunities and events happening behind the scenes. You have to sift through a bit of the inconsequential emails though.

Lastly, been doing a ton of reading on delta variant, hospitalizations and the real impact this could have on travel as I add to my SABR and COTY positions. Few interesting things I found:

"On Wednesday, the Delta variant became America’s dominant COVID strain. Yet it’s no cause for panic: The numbers — especially in Britain, which Delta hit hard — show it causes far fewer hospitalizations and deaths, while vaccines remain highly effective against it."

"Yes, Delta, does appear more contagious than the Alpha variant about 50 percent more transmissible, which is why it’s outpaced Alpha there. The huge UK case spike didn’t lead to similar hospitalization or death spikes, so Britain’s back on track to lift regulations July 19."

"The seven-day average of new UK cases is above 25,000, the highest since late January, when the weekly average had just dropped from a peak of 50,000. But only 2,000 COVID cases are hospitalized, vs. nearly 40,000 in January. Daily deaths average under 20, vs. more than 1,000 in January."

"And while Delta caused a 10 percent rise in daily US cases late last month, COVID hospital admissions actually dropped."

Anyways, the conclusions here I think are all similar, these are media tactics to say the delta variant is significantly worse. As we are seeing, it is much more contagious but significantly less deadly and leading to less hospitalizations. Also the data shows the uptick in cases are in cities/countries with very low vax rates. All in all, personally I think this is an over-reaction and why I think this is a bit oversold creating an opportunity to average down.

I’m allocating to shares of ASPL, at $9.80 just seems so cheap to me and I will sell covered calls on them should we see some movement after the merger closes.

Also exactly correct Re Delta variant. In general in infectious disease, if something passes from one person to the next rapidly, the propensity for very poor outcomes is low - if outcomes were severe, that person would be too ill to be able to pass on the disease (ie in bed at home, in a hospital unit, or deceased). That is what MERS was - extremely deadly, tended to kill the host before having the chance to be transmitted on many others. Common cold is the opposite - not usually deadly, so it’s easy to spread to a large number of people as we all recall that person at the office who would show up with a sneeze and a bag of Kleenex. Similar idea applies to covid strains (covid, common cold and MERS are all part of the coronavirus family). I have heard a bit about the new lambda variant as well - seems fast moving as well, and current data suggests vaccines will remain protective but more studies are needed still. I do think we will continue to see new variants of covid all the time, much like the flu. Might be in for an annual booster in a similar fashion. Nonetheless, I remain optimistic, especially for our 2023 calls.

[vipereaper30]

It's put up or shut up time going into Q4 for Corvus Pharmaceuticals, and the market is not expressing much confidence in their outlook. Watching closely for results of CPI-006 Phase 3 trials as well as initiation of Phase 2 of CPI-818 with their project in China with Angel.

Would love to see positive data on 006 but not expecting a knockout for COVID. Hopeful that data strongly supports immunostimulatory capabilities that will be used in other indications, particularly cancer.

Still trying to figure out the value of Angel. Any others invested here with thoughts on pre-clinical biotech potential in the Chinese market? CRVS in particular?

[7sins]

Originally Posted by vipereaper30

That article should have been titled "Due to TRF Investment Club, Sabre call volume above normal and directionally bullish"

:strong:

I might need to change my username by 2023 if it doesnt work out

Originally Posted by logo

I’m allocating to shares of ASPL, at $9.80 just seems so cheap to me and I will sell covered calls on them should we see some movement after the merger closes.

Also exactly correct Re Delta variant. In general in infectious disease, if something passes from one person to the next rapidly, the propensity for very poor outcomes is low - if outcomes were severe, that person would be too ill to be able to pass on the disease (ie in bed at home, in a hospital unit, or deceased). That is what MERS was - extremely deadly, tended to kill the host before having the chance to be transmitted on many others. Common cold is the opposite - not usually deadly, so it’s easy to spread to a large number of people as we all recall that person at the office who would show up with a sneeze and a bag of Kleenex. Similar idea applies to covid strains (covid, common cold and MERS are all part of the coronavirus family). I have heard a bit about the new lambda variant as well - seems fast moving as well, and current data suggests vaccines will remain protective but more studies are needed still. I do think we will continue to see new variants of covid all the time, much like the flu. Might be in for an annual booster in a similar fashion. Nonetheless, I remain optimistic, especially for our 2023 calls.

Thank you Logo as always, appreciate your insight being from the medical field. I'm following your lead on ASPL, going to dip my toes and see what happens, I believe vote is today so merger should be complete with ticker change this week.

Originally Posted by vipereaper30

It's put up or shut up time going into Q4 for Corvus Pharmaceuticals, and the market is not expressing much confidence in their outlook. Watching closely for results of CPI-006 Phase 3 trials as well as initiation of Phase 2 of CPI-818 with their project in China with Angel.

Would love to see positive data on 006 but not expecting a knockout for COVID. Hopeful that data strongly supports immunostimulatory capabilities that will be used in other indications, particularly cancer.

Still trying to figure out the value of Angel. Any others invested here with thoughts on pre-clinical biotech potential in the Chinese market? CRVS in particular?

Bit of a tangent, what are you thinking on $AUPH? It has been quite frustrating being in it from last year, I averaged down significantly in the $10s after last ER fiasco but it just isn't moving much. Despite all the positive news for Voclosporin and clearly the leading treatment now for Lupynis, I suspect will be SoC of soon. From what I am reading, sales are terribly slow as most doctors feel the current treatment is "good enough" and not seeing much of a push from the salesforce. Really is perplexing given how incredible of a drug and treatment it is with 2037 patent protection with only one real competitor that AUPH is clearly superior to.

I'm not sure they ever intended to go to market in hopes of a BO prior which would explain the many recent inefficiencies and sheer incompetency from management. They projected $1B in peak sales, at 25% margin ,which most analysts were putting a $3B price tag on it or roughly $25 - which leaves nice upside from here. Have to imagine next ER is going to be a disaster without any further news on a BO given the very slow growth of sales and zero communication from Peter.

[jaisonline]

I love my Weber grills (own 2).
Easily one of the top manufacturers (including Napoleon). There are more expensive companies but many of them. don’t have the reliability.

https://www.bloomberg.com/news/artic...id-to-plan-ipo

On the heels of the July 4 holiday, another U.S. grill maker is planning to go public.

Weber-Stephen Products LLC, the maker of Weber grills, is planning an initial public offering this year, according to people with knowledge of the matter. The company is seeking to be valued at $4 billion to $6 billion, one of the people said.

The company has tapped Goldman Sachs Group Inc. and Bank of America Corp. to lead the offering, the people said, asking not to be identified discussing private information.

BDT Capital Partners, the Chicago-based investment firm and merchant bank founded and led by Byron Trott, has been the majority owner of the manufacturer since 2010.

Representatives for Weber, based in Palatine, Illinois, and Bank of America declined to comment. BDT and Goldman Sachs didn’t respond to requests for comment.

Weber’s IPO plans follow Tuesday’s filing by smaller rival Traeger Inc. While Weber is a mass-market brand, Traeger targets more-skilled home cooks, selling mobile-app connected grills costing up to $1,999.99 each.

Home-goods companies have gotten a boost from the extended period of lock-down during the coronavirus pandemic, during which people have spent more time at their homes and more money on them.

Weber, which calls itself the largest manufacturer of grills and grilling accessories, raised $1.55 billion in debt in October. That financing was led by Bank of America, according to a statement at the time.

[7sins]

Interesting note today from Goldman Sachs Chief Equity Strategist listing their top 32 picks for the rest of the year, mostly based on expanding profit margins (30%+). A lot of familiar names but a few to look more under the hood.

[AshCashEmAll]

I’m getting crusheddd mates. Heavy in coty and sabr


Sent from my iPhone using Tapatalk

[CoveWatch]

Originally Posted by jaisonline

I love my Weber grills (own 2).
Easily one of the top manufacturers (including Napoleon). There are more expensive companies but many of them. don’t have the reliability.

https://www.bloomberg.com/news/artic...id-to-plan-ipo

On the heels of the July 4 holiday, another U.S. grill maker is planning to go public.

Weber-Stephen Products LLC, the maker of Weber grills, is planning an initial public offering this year, according to people with knowledge of the matter. The company is seeking to be valued at $4 billion to $6 billion, one of the people said.

The company has tapped Goldman Sachs Group Inc. and Bank of America Corp. to lead the offering, the people said, asking not to be identified discussing private information.

BDT Capital Partners, the Chicago-based investment firm and merchant bank founded and led by Byron Trott, has been the majority owner of the manufacturer since 2010.

Representatives for Weber, based in Palatine, Illinois, and Bank of America declined to comment. BDT and Goldman Sachs didn’t respond to requests for comment.

Weber’s IPO plans follow Tuesday’s filing by smaller rival Traeger Inc. While Weber is a mass-market brand, Traeger targets more-skilled home cooks, selling mobile-app connected grills costing up to $1,999.99 each.

Home-goods companies have gotten a boost from the extended period of lock-down during the coronavirus pandemic, during which people have spent more time at their homes and more money on them.

Weber, which calls itself the largest manufacturer of grills and grilling accessories, raised $1.55 billion in debt in October. That financing was led by Bank of America, according to a statement at the time.

I own a Weber also (lotta bang for your buck imo) Altho my friends who are “real bbq’ers” only use charcoal and make fun of me for it

Are you planning on entering? Would like to hear some Bull cases if so. Seems at $4-$6b, they’re valued at approx 2-3x P/S and 26-40x net income. If they were a growth company, I’d be all over it already, but seems they already own 24% of the market so not exactly sure how they’ll capture more or expand on their TAM.

[77T]

Originally Posted by CoveWatch

but seems they already own 24% of the market so not exactly sure how they’ll capture more or expand on their TAM.

Brand devaluation downmarket via cheaper products.

They have already done that with Walmart - Jumbo Joe $75. And Smokey Joe $38 for multichannel marketing.

It’ll drive growth on the top line.


Sent from my iPhone using Tapatalk Pro

[7sins]

Originally Posted by AshCashEmAll

I’m getting crusheddd mates. Heavy in coty and sabr


Sent from my iPhone using Tapatalk

I hear you, just remember patience pays off, 2023 calls have 556 days to expiration. Been a challenging month with delta variant fears along with outflows from small caps but I'm personally using it as an opportunity to average down (it is never easy adding more to a negative position but that is an easy way for significant gains as your highest conviction trades reverse), stay the course and waiting for upcoming catalysts.

Hasn't worried me one bit, the fact SABR has given up all YTD gains this month as we have seen an uptick in travel and a great July 4th holiday weekend makes me view it as a dislocation. As long as the world doesn't shut down again, this will trend back to $15+. The market is just the transfer of wealth from the impatient to the impatient.

[CoveWatch]

Originally Posted by 77T

Brand devaluation downmarket via cheaper products.

They have already done that with Walmart - Jumbo Joe $75. And Smokey Joe $38 for multichannel marketing.

It’ll drive growth on the top line.


Sent from my iPhone using Tapatalk Pro

Hmm, interesting. Maybe that drives the top line but will undoubtedly eat into the higher margin items. (I’m assuming similar customer base) Would be interested to see how this will affect profit going forward.

[7sins]

Originally Posted by 7sins

I hear you, just remember patience pays off, 2023 calls have 556 days to expiration. Been a challenging month with delta variant fears along with outflows from small caps but I'm personally using it as an opportunity to average down (it is never easy adding more to a negative position but that is an easy way for significant gains as your highest conviction trades reverse), stay the course and waiting for upcoming catalysts.

Hasn't worried me one bit, the fact SABR has given up all YTD gains this month as we have seen an uptick in travel and a great July 4th holiday weekend makes me view it as a dislocation. As long as the world doesn't shut down again, this will trend back to $15+. The market is just the transfer of wealth from the impatient to the impatient.

Apologies, should have read as transfer of wealth from inpatient to patient. Taco Tuesday gets me every time.

[vipereaper30]

Originally Posted by 7sins

Bit of a tangent, what are you thinking on $AUPH?

Frustrating to say the least! There's no new data since the Jeffries conference that has changed my opinion here. This next quarter's ER removes the COVID excuse so if the numbers aren't dramatically improving we're in a really shitty spot. With poor growth at this stage I believe a buyout could still occur but at a valuation that isn't favorable. Likely that an offer (or offers) are currently there but not at PG's threshold, hence the appearance of mismanagement as they are stumbling with the rollout. I agree with you that they probably didn't think they'd be going it alone right now.

I haven't yet lost trust in PG or the team, but my patience is thin. One more call or conference with the same level of performance from the top and I'm likely to pull the plug on AUPH.

Pivoting back to CRVS, I'm trying to research Dr. Ted Wang of Puissance Capital (former GS partner) who is on the Angel board and integral to this new Chinese venture. http://www.angelpharma.com/?news_63/128.html

In theory there is incredible potential, not just from Dr. Miller's expertise and history, but from getting after drug development in both the US and China. I'm excited for updates later this year, and if there's anyone out there with info on Dr. Wang, and/or the Chinese pre-clinical biotech environment I'd love to hear from you.

[7sins]

Listening to the Delta earnings call today to get an insight behind the travel scenes and extrapolate domestic bookings. Article here highlighting: https://news.yahoo.com/delta-air-lin...112519365.html. Delta CEO stating delta variant having no material impact on domestic bookings and their biggest challenge is re-starting Europe travel which is more Amadeus than SABR. They are looking to turn a profit next quarter which reinforces their forecast for a pickup in travel demand and turning away from the worst of covid.

Delta Air Lines (DAL) on Wednesday reported a narrower than expected loss in the second quarter, with "accelerating demand" putting the airline back on a path to profitability - they posted a profit in June.

Most notably on business travel: “We've surveyed all our big corporations, over 90% of our corporations tell us that they're going to be meaningfully increasing their corporate travel in the third quarter from where they were in the second quarter,”

“We've all seen how much people miss travel,” he said. “When you look at the pent up demand and how many people are traveling now, it gives you that strength to keep going.”

[huncho]

hopped in to play the news on aspl with you guys. got some warrants for the long term and some 1 month calls. was able to get out of the calls at 270% after 2 trading halts lol. will average into the warrants a bit more or get some leaps after it settles

thanks for putting it on our radar logo

[huncho]

also it partnered with the nfl to give players access to rides. seems like the ceo definitely knows how to market this one so will be interesting to see where it goes

https://twitter.com/AdamSchefter/sta...895717388?s=20

[AshCashEmAll]

Originally Posted by huncho

also it partnered with the nfl to give players access to rides. seems like the ceo definitely knows how to market this one so will be interesting to see where it goes

https://twitter.com/AdamSchefter/sta...895717388?s=20

I would not be surprised if they partnered with live nation for performing artists on tour. Just at the rate this company is going.


Sent from my iPhone using Tapatalk

[logo]

Nice day for ASPL, now UP, in what I think will be the beginning of a nice period of growth to the share price and the business (great new NFLPA partnership announced recently). Some pretty crazy price action at one point lol. Only thing to watch will be if it does catch attention from the meme lords then we will have to think more carefully on where to trim, though I plan to hold for a few years so more likely I’ll sell covered calls if it goes wild given the low cost basis. Congrats to all who jumped on board!

Took today to add to my SOFI position, and still have my eye on averaging down further on SABR and COTY, mind you COTY options prices have been pretty stable through all the chaos the past few days/weeks.

[7sins]

Originally Posted by logo

Nice day for ASPL, now UP, in what I think will be the beginning of a nice period of growth to the share price and the business (great new NFLPA partnership announced recently). Some pretty crazy price action at one point lol. Only thing to watch will be if it does catch attention from the meme lords then we will have to think more carefully on where to trim, though I plan to hold for a few years so more likely I’ll sell covered calls if it goes wild given the low cost basis. Congrats to all who jumped on board!

Took today to add to my SOFI position, and still have my eye on averaging down further on SABR and COTY, mind you COTY options prices have been pretty stable through all the chaos the past few days/weeks.

Cheers on ASPL, drinks on me next time you are in LA. CEO was very impressive on CNBC this morning, love the fact he built and sold Marquis jets as well.

FYI the Dec 2023 chain on SOFI just opened, $15c (one of few strikes with enough OI) is only $1 more than Jan 2023 and buys you another year, I believe ~$8. I've been in cash from selling the warrants and deciding when to re-enter or slowly build a position, not seeing much of a floor but looks attractive here in the $15s.

[huncho]

Originally Posted by 7sins

Cheers on ASPL, drinks on me next time you are in LA. CEO was very impressive on CNBC this morning, love the fact he built and sold Marquis jets as well.

FYI the Dec 2023 chain on SOFI just opened, $15c (one of few strikes with enough OI) is only $1 more than Jan 2023 and buys you another year, I believe ~$8. I've been in cash from selling the warrants and deciding when to re-enter or slowly build a position, not seeing much of a floor but looks attractive here in the $15s.

the IV still worries me but at the same time i think it's kinda oversold at this point and $15 is pretty hard to pass up on. are you completely out of warrants or just the % you sold before the lockup period ended?

[AshCashEmAll]

I doubled down hard today on sabr and coty. Go big or go home ?


Sent from my iPhone using Tapatalk

[7sins]

Originally Posted by huncho

the IV still worries me but at the same time i think it's kinda oversold at this point and $15 is pretty hard to pass up on. are you completely out of warrants or just the % you sold before the lockup period ended?

IV is 90%+ for LEAPS , wouldn't be a bad idea to buy the stock at $16, write covered calls Jan 2023 $20C, prem is ~$6. That nets you a cost basis of ~$10, if your stock gets called away at $20, you are still positive 100%+ - use the IV to your advantage. That is my current plan but am waiting to take the income from the covered calls to buy options once the price settles, I sold a large chunk of the warrants prior to lockup and still have about 30% remaining. The warrants are trading at a 50% premium to intrinsic value currently so I am slowly trimming down that position. Still love the company and will be a long term position for me but trying to be strategic around positioning.

What's your plan?

Pulled this from another SPAC resource, you can see here at $16, SOFI is definitely more attractively valued looking at 2023E rev, or at the very least, more reasonable than it was near $25.

Originally Posted by AshCashEmAll

I doubled down hard today on sabr and coty. Go big or go home ?


Sent from my iPhone using Tapatalk

Singles and doubles work too, I would take even a bunt for this month haha. Small caps really taking a brutal beating the last few weeks. Hoping my stubborn persistence pays off in time. Just my .02 but as you average down to reduce your cost basis, I would do it slowly over a few days/weeks in case the price keeps dropping, opposed to doubling down all in one day.

[AshCashEmAll]

Originally Posted by 7sins

IV is 90%+ for LEAPS , wouldn't be a bad idea to buy the stock at $16, write covered calls Jan 2023 $20C, prem is ~$6. That nets you a cost basis of ~$10, if your stock gets called away at $20, you are still positive 100%+ - use the IV to your advantage. That is my current plan but am waiting to take the income from the covered calls to buy options once the price settles, I sold a large chunk of the warrants prior to lockup and still have about 30% remaining. The warrants are trading at a 50% premium to intrinsic value currently so I am slowly trimming down that position. Still love the company and will be a long term position for me but trying to be strategic around positioning.

What's your plan?

Pulled this from another SPAC resource, you can see here at $16, SOFI is definitely more attractively valued looking at 2023E rev, or at the very least, more reasonable than it was near $25.





Singles and doubles work too, I would take even a bunt for this month haha. Small caps really taking a brutal beating the last few weeks. Hoping my stubborn persistence pays off in time. Just my .02 but as you average down to reduce your cost basis, I would do it slowly over a few days/weeks in case the price keeps dropping, opposed to doubling down all in one day.

You’re definitely right I need to learn to start averaging down but I guess I just saw the huge dump today and got excited. Thank you for your advice as always.


Sent from my iPhone using Tapatalk

[huncho]

Originally Posted by 7sins

IV is 90%+ for LEAPS , wouldn't be a bad idea to buy the stock at $16, write covered calls Jan 2023 $20C, prem is ~$6. That nets you a cost basis of ~$10, if your stock gets called away at $20, you are still positive 100%+ - use the IV to your advantage. That is my current plan but am waiting to take the income from the covered calls to buy options once the price settles, I sold a large chunk of the warrants prior to lockup and still have about 30% remaining. The warrants are trading at a 50% premium to intrinsic value currently so I am slowly trimming down that position. Still love the company and will be a long term position for me but trying to be strategic around positioning.

What's your plan?

Pulled this from another SPAC resource, you can see here at $16, SOFI is definitely more attractively valued looking at 2023E rev, or at the very least, more reasonable than it was near $25.

i've just been watching from the sidelines for now. i would much rather buy leaps but with that IV if you buy jan or dec 2023 and it goes back to 25 you'd barely be up more than if you buy shares so i just don't see the point of it. i was also thinking about just buying shares because i have a bit of cash sitting around and either selling calls or just holding. might wait to see if it drops below 15 first though but we'll see. i wonder if the IV will drop a bit after their earnings come out in a few months. i was also planning on eventually exercising my warrants but now that the disconnect flipped the other way i need to figure out what to do there as well

[vipereaper30]

Originally Posted by vipereaper30

Would love to see positive data on 006 but not expecting a knockout for COVID. Hopeful that data strongly supports immunostimulatory capabilities that will be used in other indications, particularly cancer.

News about the P3 halting is nothing but positive for CRVS imo. Love a market reaction like today to average down.

https://corvuspharma.gcs-web.com/new...dy-mupadolimab

They wisely stopped a study that was getting to be impossible due to such low numbers of COVID hospitalizations. Data double blinded so no efficacy (or lack therof) indications yet, and no safety issues. All positive, I'm betting big on Dr. Miller.

[7sins]

Adding to my position in $TSM (one of largest chip manufactures in the world) today, these last two days are just downright absurd in my opinion. TSM reported yesterday, earnings beat by 11% (that is HUGE for a company of this magnitude) AND raised guidance by 20%! Stock is down 7% from yesterday and 2023 leaps are getting crushed by 25% in TWO days. Additionally QCOM is switching 5G chip orders from Samsung, this would make them TSMC's 2nd largest client for 7nm/6nm process in 2021. Lastly as the build their AZ plant this will limit political risk as Biden wants to significantly increase domestic chip production. Chip demand I do not foresee subsiding in the near future. Average analyst PO is $140. Besides ASML this is my favorite play in the space but believe ASML is still too pricey.

Just my .02 but this selloff is completely unnecessary. My own play is buying as much as I can at $115 and anything below, today I bought ATM Jan 2023 $115C for only $17 (ytd high on this option as $45, even most recent when TSM hit $124 these were $23)as core. If we see dip further down, I will buy farther OTM. As always, not investment advice but just a position I will continue to build at these levels into next year.

[huncho]

this week has just been slow and steady bleeding lol. grabbed some more viacom today because it seems to be getting crushed for no reason again...looking to add a bit to intel as well but gonna hold off til earnings after seeing what happened to tsm

hopefully next week is better

[vipereaper30]

Looks like we're all buying into weakness on many of our picks. I'll be over here licking wounds and applying my rally cap for next week.

CRVS 10% off the lows this AM, didn't buy nearly as much as I would have liked. Leaving room to continue adding in case of further weakness.

[MrGoat]

Anybody else getting killed on MSTR? I’m holding at the moment. Don’t know where I should dump at or hold with hopes it comes back. I’m about 18% underwater on it right now.


Sent from my iPhone using Tapatalk

[huncho]

Originally Posted by MrGoat

Anybody else getting killed on MSTR? I’m holding at the moment. Don’t know where I should dump at or hold with hopes it comes back. I’m about 18% underwater on it right now.


Sent from my iPhone using Tapatalk

not in mstr but in bitcoin directly. it really comes down to how you feel about bitcoin. im super bullish on it long term but the short term looks a bit rough, lot of good news and adoption but nothing seems to be pushing it out of this "crash". 18% isn't too bad considering what it's directly tied to and how it dropped 50% already. for what it's worth, hedge funds are using mstr to indirectly invest in bitcoin and the stats say that every month more and more bitcoins are being taken from exchanges and held by those buying them, but this won't reflect in the price in real time since it's done otc. there just needs to be some catalyst that kicks it back off (another big s&p company announcing holdings) but until then it's just gonna range and it might sit there for even a year. just depends on how much you have in it and whether you'd rather make money elsewhere in the mean time